Patent_ductus_Arteriosus_flashcards
What is Patent Ductus Arteriosus (PDA)?
PDA is a form of congenital heart defect.
How is PDA generally classified?
PDA is generally classed as ‘acyanotic’.
What can uncorrected PDA eventually result in?
Uncorrected PDA can eventually result in late cyanosis in the lower extremities, termed differential cyanosis.
Where is the connection in PDA?
In PDA, there is a connection between the pulmonary trunk and descending aorta.
What causes the ductus arteriosus to close after birth?
The ductus arteriosus usually closes with the first breaths due to increased pulmonary flow which enhances prostaglandin clearance.
In which groups is PDA more common?
PDA is more common in premature babies, babies born at high altitude, or those with maternal rubella infection in the first trimester.
What are some features of PDA?
Features of PDA include a left subclavicular thrill, continuous ‘machinery’ murmur, large volume bounding collapsing pulse, wide pulse pressure, and heaving apex beat.
What kind of murmur is associated with PDA?
A continuous ‘machinery’ murmur is associated with PDA.
Describe the pulse in PDA.
The pulse in PDA is large volume, bounding, and collapsing.
What is the management for PDA?
Management for PDA includes the use of indomethacin or ibuprofen.
How does indomethacin or ibuprofen help in PDA?
Indomethacin or ibuprofen inhibits prostaglandin synthesis, which closes the connection in the majority of cases.
What is the role of prostaglandin E1 in PDA management?
If PDA is associated with another congenital heart defect amenable to surgery, prostaglandin E1 is useful to keep the duct open until after surgical repair.
Summarise Patent ductus arteriosus
Patent ductus arteriosus
Overview
a form of congenital heart defect
generally classed as ‘acyanotic’. However, uncorrected can eventually result in late cyanosis in the lower extremities, termed differential cyanosis
connection between the pulmonary trunk and descending aorta
usually, the ductus arteriosus closes with the first breaths due to increased pulmonary flow which enhances prostaglandins clearance
more common in premature babies, born at high altitude or maternal rubella infection in the first trimester
Features
left subclavicular thrill
continuous ‘machinery’ murmur
large volume, bounding, collapsing pulse
wide pulse pressure
heaving apex beat
Management
indomethacin or ibuprofen
given to the neonate
inhibits prostaglandin synthesis
closes the connection in the majority of cases
if associated with another congenital heart defect amenable to surgery then prostaglandin E1 is useful to keep the duct open until after surgical repair
You are asked to review a neonate born pre-term at 35 weeks, 36-hours after delivery with no complications.
On examination, you find a left subclavicular thrill and notice a continuous ‘machinery-like’ murmur. You also discover a bounding pulse and note a widened pulse pressure.
There is no evidence of cyanosis, nor crackles on auscultation.
Upon reviewing the notes and history with the mother, there were no problems during the pregnancy, nor any abnormal findings on antenatal scans or screening. There is no family history of any significant disease.
Given the likely diagnosis, what would be the most appropriate management option?
Give indomethacin to the mother
Give indomethacin to the neonate
Reassure the mother and monitor over the coming months
Request a review from the surgical team
Give prostaglandin E1 to the neonate
Give indomethacin to the neonate
Indomethacin or ibuprofen is used in patent ductus arteriosus to promote duct closure
Giving indomethacin to the neonate is the correct answer, as the examination findings point toward a diagnosis of patent ductus arteriosus (PDA). The ductus arteriosus usually closes with the first breaths, which clear the prostaglandins keeping it open. When this does not occur, indomethacin or ibuprofen can be given, as these inhibit prostaglandin synthesis.
Giving indomethacin to the mother would not achieve this - it needs to be given to the neonate.
Prostaglandin would have the opposite effect, and would maintain the PDA’s patency. This would be useful if surgical repair was warranted - if a congenital heart disease was also discovered upon investigation. The lack of family history, and normal screening/scans during pregnancy make that unlikely in this scenario.
The same applies to the option of getting the surgeons involved.
Reassuring the mother and monitoring over the coming months would not be appropriate. For now, the baby is acyanotic, but if left untreated, can lead to pulmonary hypertension, or Eisenmenger’s syndrome - reversal of the shunt from left-to-right (acyanotic), to right-to-left (cyanotic).
The ward doctor is asked to review a 12-hour-old neonate, born at 34 weeks gestation to a healthy mother during an otherwise-uncomplicated vaginal delivery. On examination, the neonate looks comfortable. A continuous ‘machinery-like’ murmur is noted on auscultation of the heart, as well as a left-sided thrill. The apex beat appears to be heaving on palpation. A widened pulse pressure is noted. There is no visible cyanosis. An echocardiogram is subsequently performed which confirms the diagnosis, and rules out any other cardiac problems.
Given the likely diagnosis, what is the most appropriate management at this stage?
Indomethacin given to the neonate
Percutaneous intervention
Refer for elective surgery
Refer for urgent surgery
Prostaglandin E1 given to the neonate
Indomethacin given to the neonate
Patent ductus arteriosus: indomethacin is given to the neonate in the postnatal period, not to the mother in the antenatal period
The likely diagnosis here, given the findings, is that of patent ductus arteriosus (PDA). The correct answer is therefore giving indomethacin to the neonate, as this prompts duct closure in the majority of cases.
The echocardiogram ruled out other defects - however, if another defect was present, it may be preferable to use prostaglandin E1 to keep the duct open until after surgical repair.
At this stage, referral for surgery is thus unwarranted.
Percutaneous closure may be used for duct closure in older children, to avoid surgery. However, this would not be suitable in a neonate.